175 related articles for article (PubMed ID: 28819574)
1. Sequential Kinase Inhibition (Idelalisib/Ibrutinib) Induces Clinical Remission in B-Cell Prolymphocytic Leukemia Harboring a 17p Deletion.
Coelho H; Badior M; Melo T
Case Rep Hematol; 2017; 2017():8563218. PubMed ID: 28819574
[TBL] [Abstract][Full Text] [Related]
2. Successful allogeneic hematopoietic stem cell transplantation with reduced-intensity conditioning for B-cell prolymphocytic leukemia in partial remission.
Arima H; Ono Y; Tabata S; Matsushita A; Hashimoto H; Ishikawa T; Takahashi T
Int J Hematol; 2014 Apr; 99(4):519-22. PubMed ID: 24470149
[TBL] [Abstract][Full Text] [Related]
3. B and T cell prolymphocytic leukaemia.
Cross M; Dearden C
Best Pract Res Clin Haematol; 2019 Sep; 32(3):217-228. PubMed ID: 31585622
[TBL] [Abstract][Full Text] [Related]
4. Haploidentical Stem Cell Transplantation Using Post-Transplant Cyclophosphamide for T-Cell Prolymphocytic Leukemia after Alemtuzumab Induction Therapy: A Case Report.
Okada N; Yamamoto R; Maruoka H; Himeno M; Hiramoto N; Ishikawa T
Case Rep Oncol; 2023; 16(1):604-612. PubMed ID: 37900793
[TBL] [Abstract][Full Text] [Related]
5. Effective upfront treatment with low-dose ibrutinib for a patient with B cell prolymphocytic leukemia.
Oka S; Ono K; Nohgawa M
Invest New Drugs; 2020 Oct; 38(5):1598-1600. PubMed ID: 31965420
[TBL] [Abstract][Full Text] [Related]
6. B-cell Prolymphocytic Leukemia: Case Report and Challenges on a Diagnostic and Therapeutic Forefront.
Bindra BS; Kaur H; Portillo S; Emiloju O; Garcia de de Jesus K
Cureus; 2019 Sep; 11(9):e5629. PubMed ID: 31700732
[TBL] [Abstract][Full Text] [Related]
7. Sustained MRD negative remission in del17p and TP53 mutated B cell prolymphocytic leukemia with ibrutinib and venetoclax.
Siddiqui MT; Price A; Ferrajoli A; Borthakur G
Leuk Res Rep; 2021; 16():100266. PubMed ID: 34692401
[TBL] [Abstract][Full Text] [Related]
8. Management of prolymphocytic leukemia.
Dearden C
Hematology Am Soc Hematol Educ Program; 2015; 2015():361-7. PubMed ID: 26637744
[TBL] [Abstract][Full Text] [Related]
9. B-cell prolymphocytic leukemia with P53 abnormalities successfully treated with bendamustine and rituximab: a report of three cases.
Wang A; Guo W; Damiani D; Sumbly V; Goyal G; Du Z; Bai O
Transl Cancer Res; 2023 Jul; 12(7):1873-1882. PubMed ID: 37588745
[TBL] [Abstract][Full Text] [Related]
10. How I treat prolymphocytic leukemia.
Dearden C
Blood; 2012 Jul; 120(3):538-51. PubMed ID: 22649104
[TBL] [Abstract][Full Text] [Related]
11. Advances and Perspectives in the Treatment of T-PLL.
Braun T; von Jan J; Wahnschaffe L; Herling M
Curr Hematol Malig Rep; 2020 Apr; 15(2):113-124. PubMed ID: 32034661
[TBL] [Abstract][Full Text] [Related]
12. An unusual presentation of a chronic lymphocytic leukemia patient with 17p deletion after reduced-intensity transplantation: Richter syndrome and concomitant graft-versus-host disease--case report.
Salihoglu A; Ozbalak M; Keskin D; Tecimer T; Soysal T; Ferhanoglu B
Transplant Proc; 2013 Sep; 45(7):2845-8. PubMed ID: 23747187
[TBL] [Abstract][Full Text] [Related]
13. Effect of allogeneic hematopoietic cell transplantation for patients with T-prolymphocytic leukemia: a retrospective study from the Adult Lymphoma Working Group of the Japan Society for hematopoietic cell transplantation.
Yamasaki S; Nitta H; Kondo E; Uchida N; Miyazaki T; Ishiyama K; Kiyota M; Matsuoka H; Ichinohe T; Fukuda T; Atsuta Y; Suzumiya J; Suzuki R
Ann Hematol; 2019 Sep; 98(9):2213-2220. PubMed ID: 31327025
[TBL] [Abstract][Full Text] [Related]
14. Allogeneic hematopoietic cell transplantation in T-cell prolymphocytic leukemia: A single-center experience.
Dholaria BR; Ayala E; Sokol L; Nishihori T; Chavez JC; Hussaini M; Kumar A; Kharfan-Dabaja MA
Leuk Res; 2018 Apr; 67():1-5. PubMed ID: 29407180
[TBL] [Abstract][Full Text] [Related]
15. A patient with white blood cell counts more than a million: A diagnostic and therapeutic challenge.
Figueroa-Jiménez LA; Cabrera-Márquez AL; Báez-Díaz L; Cáceres-Perkins W
Bisturi (S Juan); 2016; 2016():12-16. PubMed ID: 29238632
[TBL] [Abstract][Full Text] [Related]
16. Allogeneic bone marrow transplantation in a patient with T-prolymphocytic leukemia with small-intestinal involvement.
Murase K; Matsunaga T; Sato T; Kuribayashi K; Kogawa K; Kawano Y; Okamoto T; Takayama T; Watanabe H; Niitsu Y; Hirayama Y
Int J Clin Oncol; 2003 Dec; 8(6):391-4. PubMed ID: 14663643
[TBL] [Abstract][Full Text] [Related]
17. Prolymphocytic Leukemia: New Insights in Diagnosis and in Treatment.
Collignon A; Wanquet A; Maitre E; Cornet E; Troussard X; Aurran-Schleinitz T
Curr Oncol Rep; 2017 Apr; 19(4):29. PubMed ID: 28324286
[TBL] [Abstract][Full Text] [Related]
18. B- and T-cell prolymphocytic leukemia: antibody approaches.
Dearden C
Hematology Am Soc Hematol Educ Program; 2012; 2012():645-51. PubMed ID: 23233647
[TBL] [Abstract][Full Text] [Related]
19. Hematopoietic stem cell transplantation in T-prolymphocytic leukemia: a retrospective study from the European Group for Blood and Marrow Transplantation and the Royal Marsden Consortium.
Wiktor-Jedrzejczak W; Dearden C; de Wreede L; van Biezen A; Brinch L; Leblond V; Brune M; Volin L; Kazmi M; Nagler A; Schetelig J; de Witte T; Dreger P;
Leukemia; 2012 May; 26(5):972-6. PubMed ID: 22116553
[TBL] [Abstract][Full Text] [Related]
20. Partial response to venetoclax and ruxolitinib combination in a case of refractory T-prolymphocytic leukemia.
Brothers J; Castillo DR; Jeon WJ; Joung B; Linhares Y
Hematology; 2023 Dec; 28(1):2237342. PubMed ID: 37485976
[No Abstract] [Full Text] [Related]
[Next] [New Search]